Abstract
Many cases of depression in women are due to endocrine factors and inappropriate treatment by antidepressants or mood-stabilizing drugs such as lithium. The syndrome reproductive depression includes premenstrual depression (PMDD), postnatal depression (PND) and climacteric depression which is more severe in the transitional phase 2 or 3 years before the periods cease rather than in the years after the menopause. Such patients are usually free of depression during pregnancy. The diagnosis cannot be made by measuring hormone levels but by a careful history relating depression to monthly cycles and the postnatal state. The range and aetiology of depression in women is different than in men and cannot be understood without knowledge of the effect that oestrogen, progesterone and androgens have upon mood. These frequent problems are usually treated badly by psychiatrists who have little knowledge and less interest in the effect of hormones on mood. Treatment should be by oestrogens preferably by the transdermal route possibly with the addition of testosterone and if necessary the addition of progesterone to protect the endometrium.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dickens C. Household words, vol. 95. New York, NY: D. Appleton; 1852. p. 385–9.
Studd J. A guide to hormone therapy for the treatment of depression in women. Climacteric. 2011;14:637–42.
Studd J, Nappi RE. Reproductive Depression. Gynecol Endocrinol. 2012;28(Suppl 1):42–5.
Nappi RE, Tonani S, Santamaria V, Ornati A, Albani F, Pisani C, Polatti F. Luteal phase dysphoric disorder and premenstrual syndrome. It J Psych. 2009;28:27–33.
Burger HG, Hale GE, Robertson DN, Dennerstein L. A review of hormonal changes during the menopausal transition. Hum Reprod Update. 2007;13:559–65.
Craig MC. Should psychiatrist be prescribing oestrogen therapy to their patients? Br J Psychiatry. 2013;202(1):9–13.
Ismaili E, Walsh S, O’Brien PMS, et al. Fourth consensus of the international society of premenstrual disorders (ISPMD): auditable standards for the diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016;19(6):953–8.
Wessel Skovlund C, Steinrud Morch L, Vedel Kessing L, Liddegaard O. Association of hormonal contraception with depression. JAMA Psychiat. 2016;73(11):1154–62.
Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update. 1997;3:159–71.
Watson NR, Studd JWW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet. 1989;8665:730–2.
Elovainio M, Teperi J, Aalto AM. Depressive symptoms as predictors of discontinuation of levonorgestrel releasing intrauterine system. Int J Behav Med. 2007;14:70–5.
Leather AT, Studd JW, Watson NR, Holland EF. The treatment of severe premenstrual syndrome with goserelin with and without ‘add-back’ estrogen therapy: a placebo-controlled study. Gynecol Endocrinol. 1999;13:48–55.
Leather AT, Studd JWW, Watson NR, Holland EFN. The prevention of bone loss in young women treated with GnRh analogues with ‘add back’ oestrogen therapy. Obstet Gynecol. 1993;81:104–7.
Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM. The effectiveness of GnRH analogue with and without “addback” therapy in treating premenstrual syndrome: a meta analysis. BJOG. 2004;111:585–93.
Di Carlo C, Palomba S, GAm T, et al. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril. 2001;76:850–2.
Casson P, Hahn PM, Van Vugt DA, Reed RL. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am Obstet Gynecol. 1990;162:99–105.
Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod. 2004;19:2152–5.
Studd J. Severe premenstrual syndrome and bipolar disorder; a frequent tragic confusion. Menopause Int. 2012;18:65–7.
Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstet Gynecol. 2018;1:68–74.
Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000;157:924–30.
Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal estrogen for the treatment of severe post-natal depression. Lancet. 1996;347:930–3.
Dennis CL, Ross LE, Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst Rev. 2008;4:CD001690.
Dennerstein L, Lehert P, Burger H, et al. Mood and the menopausal transition. J Nerv Ment Dis. 1999;187:685–91.
Brincat M, Magos A, Studd JW, et al. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet. 1984;1:16–8.
Soares CN, Almeida JH, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58:529–34.
Montgomery JC, Brincat M, Tapp A, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1987;1:297–9.
Studd J. HRT should be considered as first line therapy for perimenopausal depression: FOR: estrogens are the first line treatment for perimenopausal women. BJOG. 2016;123:1011.
Craig MC. HRT should be considered as first line therapy for perimenopausal depression: against: more clinical trials are needed. BJOG. 2016;123:1011.
Gath D, Rose N, Bond A, et al. Hysterectomy and psychiatric disorder. Psychol Med. 1995;25:277–83.
Khastgir G, Studd J. Patient’s outlook experience and satisfaction with hysterectomy bilateral oophorectomy and subsequent hormone replacement therapy. Am J Obstet Gynecol. 2000;183:1427–33.
Studd J. Hysterectomy A life saving as well life enhancing operation. Menopause Int. 2009;15:2–3.
Graziottin A, Serafini A. Depression and the menopause: why antidepressants are not enough? Menopause Int. 2009;15:76–81.
Studd J. Hormone therapy for reproductive depression in women. Post Reprod Health. 2014;20(4):132–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 International Society of Gynecological Endocrinology
About this chapter
Cite this chapter
Studd, J.W., Savvas, M., Watson, N. (2019). Reproductive Depression and the Response to Hormone Therapy. In: Brinton, R., Genazzani, A., Simoncini, T., Stevenson, J. (eds) Sex Steroids' Effects on Brain, Heart and Vessels. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-030-11355-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-11355-1_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11354-4
Online ISBN: 978-3-030-11355-1
eBook Packages: MedicineMedicine (R0)